HALL LAURIE J TRUSTEE - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 136 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$1
-99.9%
1350.0%0.00%
Q3 2022$1,0000.0%135
-32.5%
0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,0000.0%2000.0%0.00%
Q4 2021$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2021$2,000
-71.4%
200
-37.5%
0.00%
-66.7%
Q2 2021$7,000
-22.2%
3200.0%0.00%0.0%
Q1 2021$9,000
+12.5%
3200.0%0.00%0.0%
Q4 2020$8,0000.0%320
+45.5%
0.00%
-25.0%
Q3 2020$8,000
-20.0%
220
+29.4%
0.00%
-20.0%
Q4 2019$10,000
+150.0%
170
+70.0%
0.01%
+150.0%
Q3 2019$4,000
+33.3%
100
+42.9%
0.00%0.0%
Q2 2019$3,0000.0%700.0%0.00%0.0%
Q1 2019$3,0000.0%700.0%0.00%0.0%
Q4 2018$3,000
-25.0%
70
-12.5%
0.00%0.0%
Q3 2018$4,000
+33.3%
800.0%0.00%0.0%
Q2 2018$3,000
-78.6%
80
-57.9%
0.00%
-77.8%
Q1 2018$14,000
+7.7%
1900.0%0.01%
+28.6%
Q4 2017$13,000
-99.9%
190
-32.1%
0.01%
-22.2%
Q3 2017$14,034,000
+8.3%
2800.0%0.01%
+12.5%
Q2 2017$12,958,000
+29.7%
2800.0%0.01%
+33.3%
Q1 2017$9,988,0002800.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$59,618,00021.09%
Bellevue Group AG 4,519,164$95,580,0000.93%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$36,234,0000.84%
Rhenman & Partners Asset Management AB 572,267$12,103,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 64,434$1,363,0000.45%
Boxer Capital, LLC 500,000$10,575,0000.37%
EMC Capital Management 27,566$583,0000.33%
WASATCH ADVISORS LP 3,766,935$79,671,0000.32%
Avidity Partners Management LP 400,000$8,460,0000.23%
Cinctive Capital Management LP 186,170$3,937,0000.18%
View complete list of ESPERION THERAPEUTICS INC NE shareholders